In 2018, pharma markets in the world’s 60 richest countries will grow by almost 5% compared to the previous year. However in regions such as Europe, the effort to hold down drug prices will continue – in western Europe, where pharmaceuticals now account for less than 10% of healthcare spending, and the room for manoeuvre is getting smaller.

What are the five key trends to watch in 2018 across the world’s pharma markets, and how can companies respond?

From healthcare reforms that impact access to medicines; to advances in biotech and technology that will redefine healthcare, 2018 is a year for pharmas to watch closely.